Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
about
Performing meta-analysis with incomplete statistical information in clinical trialsProspective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension.Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionA randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostIntraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma.Travoprost in the management of open-angle glaucoma and ocular hypertensionEfficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre studyBimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patientsDemonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy.A review of the use of latanoprost for glaucoma since its launch.Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure.Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits.Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions.Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits.Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations.Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis.Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.A novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost.Intraocular Pressure and Conjunctival Hyperaemia with Bimatoprost Every 48 Hours Versus Every 24 Hours.
P2860
Q33360471-70CD0B1B-1067-4ADA-B95A-2E7B0F7A93D6Q33596855-C3D321BC-B044-462A-9ADA-90B37BB655AFQ33790393-73BCC73B-F133-4C87-A08C-FE8274102AADQ34043309-E62A90B1-63DB-4FDC-AF99-23208F6606C2Q34399842-9528A0C7-28EC-48FB-B3F8-136E0D19034BQ35102806-7EDDCD0B-65B2-4347-9255-48021C2F5D71Q35237431-77BFF6E2-F087-44F6-B669-CBD328F585CDQ37067698-06144E31-2871-4B0F-9118-1FB43FD1E564Q37236653-F52E3F6E-0D53-4C72-85DD-BF72C3F519A1Q37475890-3F29745F-B21B-4679-8409-6408CC440A47Q37697869-0C7CA69B-7030-4D2A-B5EF-7AE308141540Q37918357-C01E41A3-D06A-4798-A8E9-EE93E955D108Q37986149-ACDF0763-556C-495D-A4EF-D36B486DD5CCQ38443489-77438312-001A-44E9-A0F9-AE2C93236489Q39221538-F4FCD843-F446-4EEC-A113-1C7CFB784630Q39506959-2C328FB9-23D8-4DC2-B2B1-FFAE6083A6B9Q39791012-5BF94064-DA71-458D-8CD1-662D85C8C822Q41125727-846B7C16-86C2-4FD3-A1A1-BB42A940501BQ41767609-C051827F-D224-4BCE-AF91-9B1CC65DDB14Q42183554-FD5A6048-7FD2-474D-A4A4-4C25F4F35A66Q42841116-710198EA-BDA3-4DC5-BFBE-D5EEFE050C70Q44637557-8689606B-C4D7-4851-8163-E32690BDA67DQ45764566-E8BF22EF-A4F0-4722-8225-076F97293EB3
P2860
Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Intraocular pressure-lowering ...... aucoma or ocular hypertension.
@ast
Intraocular pressure-lowering ...... aucoma or ocular hypertension.
@en
type
label
Intraocular pressure-lowering ...... aucoma or ocular hypertension.
@ast
Intraocular pressure-lowering ...... aucoma or ocular hypertension.
@en
prefLabel
Intraocular pressure-lowering ...... aucoma or ocular hypertension.
@ast
Intraocular pressure-lowering ...... aucoma or ocular hypertension.
@en
P2093
P2860
P356
P1476
Intraocular pressure-lowering ...... aucoma or ocular hypertension.
@en
P2093
Bimatoprost-Travoprost Study Group
L B Cantor
P2860
P304
P356
10.1136/BJO.2006.094326
P407
P577
2006-07-06T00:00:00Z